#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16700	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2659	763.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1649	1649	C	1068	C,T,G	1066,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16700	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2659	763.4	0	HET	.	.	.	C207T,A	.	207	207	C	672	672	C	899	C,T,A	467,431,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4112	856.8	0	.	n	.	0	T695C	SNP	695	695	T	1289	1289	C	1048	C,T,G,A	1042,2,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4112	856.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2565	2565	C	1019	C,T,A	1016,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4112	856.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2639	2639	A	976	A	975	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4112	856.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3191	3191	C	963	C,T	962,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4112	856.8	0	HET	.	.	.	A1638G	.	1638	1638	A	2232	2232	A	1012	A,G	509,503	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2486	folP	855	855	100.0	folP.l15.c4.ctg.1	2228	139.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1400	1402	AGC	241;243;245	A;G,A;C	241;241,1;245	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5984	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3958	188.7	1	SNP	p	S91F	1	.	.	271	273	TTC	881	883	TTC	228;228;229	T;T,A;C	228;227,1;229	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5984	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3958	188.7	1	SNP	p	D95G	1	.	.	283	285	GGC	893	895	GGC	235;239;241	G,A;G,C;C	233,1;237,1;240	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5984	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3958	188.7	1	SNP	p	G95N	0	.	.	283	285	GGC	893	895	GGC	235;239;241	G,A;G,C;C	233,1;237,1;240	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2276	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1810	156.8	1	SNP	p	G45D	0	.	.	133	135	GGC	702	704	GGC	242;242;241	G;G;C	242;242;241	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1208	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1495	100.9	0	.	n	.	0	A197.	DEL	197	197	A	852	852	A	237	A,G	236,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3565	189.7	1	SNP	p	D86N	0	.	.	256	258	GAC	904	906	GAC	263;265;264	G,T;A;C	262,1;265;264	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3565	189.7	1	SNP	p	R87I	0	.	.	259	261	CGT	907	909	CGT	264;266;268	C,A;G;T,G,C	263,1;266;266,1,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3565	189.7	1	SNP	p	R87W	0	.	.	259	261	CGT	907	909	CGT	264;266;268	C,A;G;T,G,C	263,1;266;266,1,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3565	189.7	1	SNP	p	S87R	1	.	.	259	261	CGT	907	909	CGT	264;266;268	C,A;G;T,G,C	263,1;266;266,1,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3565	189.7	1	SNP	p	S88P	0	.	.	262	264	TCC	910	912	TCC	269;267;268	T,C;C;C	268,1;267;268	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4760	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3196	185.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1843	1845	GGC	284;284;282	G;G;C	284;284;282	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1496	1498	GCC	266;267;268	G,A;C;C,A	265,1;267;266,2	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1499	1501	ATG	270;271;269	A;T;G	270;271;269	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1511	1513	ACC	268;266;266	A;C;C	268;266;266	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1511	1513	ACC	268;266;266	A;C;C	268;266;266	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2012	2014	ACC	283;284;281	A,C;C,T,A;C	282,1;282,1,1;281	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2066	2068	GCG	284;283;280	G;C;G	284;283;280	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2066	2068	GCG	284;283;280	G;C;G	284;283;280	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2189	2191	GGT	240;236;237	G,T,C;G;T	238,1,1;236;237	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2198	2200	AGC	238;240;238	A;G,T;C	238;239,1;238	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4640	penA	1746	1746	100.0	penA.l15.c4.ctg.1	3009	192.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2216	2218	CCG	239;238;240	C;C,T;G,A	239;237,1;239,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6258	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3496	223.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1829	1831	CCG	259;262;262	C;C;G,C	259;262;261,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2578	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2098	152.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	714	714	C	195	C,G	194,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3190	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2290	173.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	765	767	GTT	273;271;272	G;T;T	273;271;272	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3190	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2290	173.9	0	.	p	.	0	G48E	NONSYN	142	144	GGA	774	776	GAA	269;268;271	G;A;A	269;268;271	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3190	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2290	173.9	0	.	p	.	0	S217N	NONSYN	649	651	AGT	1281	1283	AAT	275;273;275	A;A;T	275;273;275	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3190	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2290	173.9	1	SNP	p	G120K	1	.	.	358	360	AAG	990	992	AAG	267;268;271	A;A;G	267;268;271	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3190	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2290	173.9	1	SNP	p	A121N	1	.	.	361	363	AAC	993	995	AAC	270;272;274	A;A;C	270;272;274	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3190	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2290	173.9	1	SNP	p	N121D	0	.	.	361	363	AAC	993	995	AAC	270;272;274	A;A;C	270;272;274	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10740	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5405	248.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1526	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1485	128.0	1	SNP	p	V57M	1	.	.	169	171	ATG	726	728	ATG	238;239;242	A;T;G	238;239;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
